FIBER SUPPLEMENT CLINICAL TRIAL SHOWS REDUCED CHOLESTEROL LEVELS
This article was originally published in The Tan Sheet
Executive Summary
FIBER SUPPLEMENT CLINICAL TRIAL SHOWS REDUCED CHOLESTEROL LEVELS in patients with "mild to moderate hypercholesterolemia," according to a study published in the May issue of the American Journal of Clinical Nutrition. Conducted by Donald Hunninghake, MD, University of Minnesota, et al., the study found that patients treated for 15 weeks with either 10 or 20 g daily of the fiber supplement had "significantly reduced" levels of total cholesterol and low-density lipoprotein (LDL) cholesterol compared to patients receiving a placebo. The fiber supplement group also showed a reduced ratio of LDL to high-density lipoprotein (HDL) cholesterol.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning